TIMCC

Protein FAM136A · Q96C01 · TIMCC on Sugi Atlas →

0 patent compounds predicted against TIMCC, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TIMCC by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
co Ihibtory Receptor in Preeclampsia PHASE4UNKNOWN
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
Pembrolizumab (MK-3475) in MM Patients With Residual Disease PHASE2COMPLETED
Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer PHASE1/PHASE2WITHDRAWN
Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 PHASE2COMPLETED
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas PHASE2COMPLETED
Quantitating the Impact of Plerixafor PHASE1/PHASE2UNKNOWN
Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation PHASE2UNKNOWN
Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients PHASE2COMPLETED
Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study) PHASE1/PHASE2WITHDRAWN
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS PHASE1UNKNOWN
Nebulised BromAc in Healthy Volunteers PHASE1COMPLETED
Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer PHASE1RECRUITING
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis EARLY_PHASE1RECRUITING
Application of 68Ga-Pentixafor PET/CT for Thymoma EARLY_PHASE1UNKNOWN
Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis nanCOMPLETED
Connexin Genotypes in Cystic Fibrosis nanUNKNOWN
The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma nanUNKNOWN
The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma nanUNKNOWN
Gap Junction Potentiation of Endothelial Function With Rotigaptide nanCOMPLETED
The Effects of Sleeve Gastrectomy on Fractalkine nanCOMPLETED
Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease nanUNKNOWN
C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia nanUNKNOWN
Measuring the Healthy Pediatric Inflammatory Response to Vaccination. nanENROLLING_BY_INVITATION
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Association of Nutrition and T Cell Immune Activity With Disease Progression in Nontuberculous Mycobacterial Pulmonary Disease nanNOT_YET_RECRUITING
Gene-Specific Responses to Exercise in Discordant Twins nanCOMPLETED
Genetics of Interstitial Cystitis nanCOMPLETED
Ccf mtDNA as a Neurodegenerative Biomarker nanUNKNOWN
Characterization Phenotypic and Genetic Study of the Intestinal Epithelial Dysplasia or Tufting Enteropathy (TE) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TIMCC binder may also engage these)

ProteinNameSimilarity
Q2HJI3 1.000 Q2HJI3 →
Q63ZH8 1.000 Q63ZH8 →
Q9CR98 0.997 Q9CR98 →
Q6PBU0 0.995 Q6PBU0 →
B0BN94 0.995 B0BN94 →
A4QNC6 0.993 A4QNC6 →
P30629 0.993 P30629 →
TIMM9 Mitochondrial import inner membrane translocase subunit Tim9 0.986 landscape →
Q3SZ93 0.985 Q3SZ93 →
Q4V7R1 0.984 Q4V7R1 →
Q9P7K0 0.984 Q9P7K0 →
Q4I6B0 0.984 Q4I6B0 →
P0CS01 0.983 P0CS01 →
Q8AVK1 0.983 Q8AVK1 →
Q616Q2 0.983 Q616Q2 →
Q9N408 0.983 Q9N408 →
Q9VTN3 0.982 Q9VTN3 →
Q61TH2 0.982 Q61TH2 →
O60220 0.982 O60220 →
Q6DGJ3 0.982 Q6DGJ3 →
Q2KIV2 0.982 Q2KIV2 →
Q9WVA2 0.982 Q9WVA2 →
Q9WV98 0.982 Q9WV98 →
Q4X0V2 0.981 Q4X0V2 →
Q6BN23 0.981 Q6BN23 →
Q3ZBS8 0.981 Q3ZBS8 →
Q75DU7 0.981 Q75DU7 →
Q9WV97 0.981 Q9WV97 →
Q6FK81 0.981 Q6FK81 →
Q7SBR3 0.981 Q7SBR3 →